One of our course objectives is to identify sources of bias and intentionally analyze inclusion, equity, and diversity in high-throughput discovery science.
Are the researchers in the Zika study that we discussed as our first case study diverse?
Do you see bias in the coronavirus assays you uncovered in PubChem BioAssays?